Heart Failure affects an estimated 64M cases globally

A Crisis Too Large to Ignore

Heart failure is one of medicine’s most costly and preventable crises, yet the tools clinicians rely on to manage it are decades out of date.

The gap between what’s needed and what’s available costs lives and billions of dollars every year.

0 M+
People affected by heart failure worldwide
0 %
Mortality rate within 5 years of diagnosis
0 %
Global 30-day hospital readmission rate
$ 0 B
Global annual economic burden
1 in 0
Adults face a lifetime risk of heart failure

The Problem

Heart failure is one of medicine’s most expensive and preventable crises.

It drives more hospitalizations and 30-day readmissions than any other condition and remains the single largest cost driver for Medicare.

Yet despite this burden, clinicians still lack a practical, reliable way to monitor cardiac filling pressures at the bedside.

Existing methods are invasive, expensive, or too complex for routine use.

That gap costs patients - and health systems - every single day.

JVPLabs exists to close that gap making the most accurate cardiac indicator accessible to every clinician, in every care setting.

Why Current Methods Fall Short

Ultrasound

Ultrasound can provide accurate JVP assessment at the bedside, but it requires specialized equipment and trained operators. Because examinations are time-consuming and resource-intensive, it is not practical for frequent, repeated monitoring in most clinical, home, or community settings.

Traditional Vitals

Daily weight, blood pressure, and symptom tracking remain the most common monitoring tools, yet they often change only after hemodynamics have already worsened. As a result, clinicians may be responding to deterioration rather than identifying risk earlier.

Implantable Devices

Implantable hemodynamic monitoring devices provide continuous physiologic data but require invasive procedures and carry significant cost. Their use is typically limited to select high-risk patients, leaving most heart failure patients without access to objective hemodynamic monitoring.

None of these methods provide what clinicians need most:

an objective, non-invasive repeatable measure of cardiac filling pressure that works in any care setting.

The Solution

JVPLabs is advancing how clinicians assess congestion in heart failure patients.

Our non-invasive technology automates Jugular Venous Pressure (JVP) assessment, providing an objective measurement associated with cardiac filling pressures and fluid status.

In about 60 seconds, trained healthcare professionals can capture a repeatable hemodynamic measurement without invasive procedures or specialized imaging equipment.

The result is a streamlined approach to obtaining objective physiologic information that can support clinical decision-making across hospital, clinic, home, and community care settings.

Clinical Benefits Across the Care Continuum

Objective, repeatable measurement every time. Validated against gold-standard ultrasound, JVPClinic eliminates the variability of manual assessment-giving every clinician consistent, reliable data they can act on with confidence.

1

Precision & Reliability


Catch deterioration before it becomes a crisis. Serial JVP measurements track fluid status over time, detecting volume overload early, before symptoms appear. This shifts care from reactive treatment to proactive intervention.

2

Trend-Based Management


60 seconds. Minimal training. Immediate results. Designed for busy clinical environments, JVPClinic fits naturally into existing vital workflows. Even elderly patients achieve 87.5% independent success after a brief training session.

3

Workflow Efficiency


One device. Every care setting. From the emergency department to the dialysis center to the outpatient clinic, JVPClinic works wherever your patients are, creating true continuity of hemodynamic monitoring across the care continuum.

4

Scalability Across Settings